We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
5l8a
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes to treat trypanosomiases.== | |
| - | + | <StructureSection load='5l8a' size='340' side='right' caption='[[5l8a]], [[Resolution|resolution]] 1.57Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5l8a]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L8A OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L8A FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6RB:1-(2-HYDROXYETHYL)-5-[(4-METHOXYNAPHTHALEN-1-YL)METHYL]-~{N}-(PHENYLMETHYL)-6,7-DIHYDRO-4~{H}-PYRAZOLO[4,3-C]PYRIDINE-3-CARBOXAMIDE'>6RB</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GLY:GLYCINE'>GLY</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr> | |
| - | [[ | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2w84|2w84]]</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l8a FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l8a OCA], [http://pdbe.org/5l8a PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l8a RCSB], [http://www.ebi.ac.uk/pdbsum/5l8a PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l8a ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
[[Category: Dawidowski, M]] | [[Category: Dawidowski, M]] | ||
[[Category: Emmanouilidis, L]] | [[Category: Emmanouilidis, L]] | ||
| + | [[Category: Popowicz, G M]] | ||
[[Category: Sattler, M]] | [[Category: Sattler, M]] | ||
| - | [[Category: | + | [[Category: Glycosome]] |
| + | [[Category: Inhibitor]] | ||
| + | [[Category: Protein-protein interaction inhibitor]] | ||
| + | [[Category: Signaling protein]] | ||
| + | [[Category: Structure-based drug discovery]] | ||
| + | [[Category: Trypanosomiasis]] | ||
Revision as of 19:16, 11 March 2017
Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes to treat trypanosomiases.
| |||||||||||
